These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35273054)

  • 1. Analysis of the relationship between sex and prescriptions for guideline-recommended therapy in peripheral arterial disease, in relation to 1-year all-cause mortality: a primary care cohort study.
    Benson RA; Okoth K; Keerthy D; Gokhale K; Adderley NJ; Nirantharakumar K; Lasserson DS
    BMJ Open; 2022 Mar; 12(3):e055952. PubMed ID: 35273054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease.
    Hsu CY; Chen YT; Su YW; Chang CC; Huang PH; Lin SJ
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2373-2381. PubMed ID: 28398564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of guideline-directed medical therapy on 5-year mortality in patients with newly diagnosed peripheral artery disease.
    Lee JH; Jeon HS; Lee JW; Youn YJ; Ahn SG; Kim H; Bae Y; Kim U; Ahn CM; Ko YG
    J Vasc Surg; 2023 Dec; 78(6):1471-1478.e3. PubMed ID: 37597591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
    Hira RS; Cowart JB; Akeroyd JM; Ramsey DJ; Pokharel Y; Nambi V; Jneid H; Deswal A; Denktas A; Taylor A; Nasir K; Ballantyne CM; Petersen LA; Virani SS
    Am J Cardiol; 2016 Oct; 118(8):1144-1149. PubMed ID: 27553104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
    McBride CL; Akeroyd JM; Ramsey DJ; Nambi V; Nasir K; Michos ED; Bush RL; Jneid H; Morris PB; Bittner VA; Ballantyne CM; Petersen LA; Virani SS
    Vasc Med; 2018 Jun; 23(3):232-240. PubMed ID: 29600737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
    Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
    Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing of Statins After Lower Extremity Revascularization Procedures in the US.
    Singh N; Ding L; Devera J; Magee GA; Garg PK
    JAMA Netw Open; 2021 Dec; 4(12):e2136014. PubMed ID: 34860245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
    Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Søgaard M; Nielsen PB; Skjøth F; Eldrup N; Larsen TB
    Circulation; 2021 Mar; 143(9):907-920. PubMed ID: 33300375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.
    Khariton Y; Patel KK; Chan PS; Pokharel Y; Wang J; Spertus JA; Safley DM; Hiatt WR; Smolderen KG
    Clin Cardiol; 2018 Nov; 41(11):1414-1422. PubMed ID: 30284297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Thuresson M; Jernberg T; Janzon M; Nordanstig J
    Eur J Prev Cardiol; 2021 Oct; 28(13):1426-1434. PubMed ID: 34695221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
    Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
    Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK.
    Cea Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    Eur J Prev Cardiol; 2017 Dec; 24(18):1927-1937. PubMed ID: 29053020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.